share_log

B of A Securities Maintains Underperform on Enfusion, Raises Price Target to $9

Benzinga ·  Mar 13 08:10

B of A Securities analyst Koji Ikeda maintains Enfusion (NYSE:ENFN) with a Underperform and raises the price target from $8 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment